Keytruda Pembrolizumab 100mg Injection belongs to a class of anti-cancer drugs known as monoclonal antibodies. Monoclonal antibodies are a relatively latest advancement in cancer treatment known as “targeted” cancer therapy.
Antibodies happen to be an important part of the human body’s immune system. Antibodies are produced by the body as a response against Antigens ( mostly proteins in a germ) that has managed to invade the body. The antibodies bind to the antigens and destroy them.
Keytruda Pembrolizumab 100mg Injection is an anti-cancer drug that works by interfering with the multiplication and spread of cancerous cells in the body. It is used for treating advanced stages of skin cancers like Melanoma that have become malignant and have spread to different parts of the body as well.
Keytruda Pembrolizumab 100mg Injection drug also helps in treatment of certain specific types of non-small cell lung cancer, metastatic and recurrent head and neck cancers as well as Hodgkin’s lymphoma in adults and kids.
Allergic reactions are common with Keytruda Pembrolizumab 100mg Injection if you spot any signs of allergy like: rashes, Hives, difficulty in breathing, lightheadedness, angioedema.
This is not a full list of all side effects that may occur with this injection. Please seek medical advice from your doctor about side effects.
- You must always inform your doctor of pharmacist about your past and present drug allergies or other allergies before taking this medication.Drug allergies to both active ingredients and inactive agents are common.